2007
DOI: 10.1016/j.dld.2006.10.015
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
44
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(50 citation statements)
references
References 14 publications
6
44
0
Order By: Relevance
“…Although the identification of many prognostic markers of HCC, such as vascular endothelial growth factor, osteopontin, and transforming growth factor-b, resulted from extensive clinical as well as basic research efforts, the available markers still are not able to accurately predict the survival of patients with HCC. [9][10][11] Thus, exploring new prognosis markers of HCC is of great importance.…”
mentioning
confidence: 99%
“…Although the identification of many prognostic markers of HCC, such as vascular endothelial growth factor, osteopontin, and transforming growth factor-b, resulted from extensive clinical as well as basic research efforts, the available markers still are not able to accurately predict the survival of patients with HCC. [9][10][11] Thus, exploring new prognosis markers of HCC is of great importance.…”
mentioning
confidence: 99%
“…In the following survival analysis, HIF-1a III and IV were considered high expression patterns while the remaining cases were considered as low expression patterns [7,11]. Expression of HBx was determined by assessing the percentage of decorated tumor cells and the staining intensity semiquanitatively [20]. The percentage of positive cells was rated as follows: 0 (no cell), 1 (1-25%), 2 (26-50%), 3 (51-75%), or 4 (76-100%).…”
Section: Immunohistochemistry Analysismentioning
confidence: 99%
“…When a tumor was detected with sonography or CT, it was recorded as a recurrence. Disease-free survival was measured from the date of hepatectomy to the time the tumor recurred, and overall survival was measured from the date of hepatectomy until the patient's death [20]. The endpoint for follow-up was set at the 5th year and the survival time was set at 60 months for those who survived for more than 5 years.…”
Section: Patient Follow-upmentioning
confidence: 99%
“…Its overexpression is associated with capsular infiltration, venous invasion, lymph node metastasis, and worse prognosis [68] . Whereas expression of KiSS-1, a metastasis suppressor gene, correlates with a shorter disease-free and overall survival and serves as an independent prognostic factor [69] .…”
Section: Metastasismentioning
confidence: 99%